Testing version — LOERadar is in active testing. Features and data may change.

NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE (DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM) | LOERadar

Viewing data from:

NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE

ANDA

DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM | A211830 | COREPHARMA LLC

1 strength0 unique patents0 unique exclusivities

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Oct 3, 2019	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 25MG;220MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Aug 22, 2019

No patent or exclusivity listings for this strength.